Sterling-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
3,219
Total Value
6447268451
Accession Number
0001398344-25-009257
Form Type
13F-HR
Manager Name
Sterling-Capital-Management
Data Enrichment
93% identified
3,009 identified210 unidentified

Holdings

3,219 positions • $6.4B total value
Manager:
Search and click to pin securities to the top
Page 151 of 161
Tenaya Therapeutics, Inc.
Shares:705
Value:$402
% of Portfolio:0.0% ($402/$6.4B)
DLH Holdings Corp.
Shares:99
Value:$401
% of Portfolio:0.0% ($401/$6.4B)
TechTarget, Inc.
Shares:27
Value:$400
% of Portfolio:0.0% ($400/$6.4B)
Real Brokerage Inc
Shares:98
Value:$398
% of Portfolio:0.0% ($398/$6.4B)
MITEK SYSTEMS INC
Shares:48
Value:$396
% of Portfolio:0.0% ($396/$6.4B)
PubMatic, Inc.
Shares:43
Value:$393
% of Portfolio:0.0% ($393/$6.4B)
Century Therapeutics, Inc.
Shares:807
Value:$384
% of Portfolio:0.0% ($384/$6.4B)
Black Diamond Therapeutics, Inc.
Shares:247
Value:$383
% of Portfolio:0.0% ($383/$6.4B)
EVERSPIN TECHNOLOGIES INC.
Shares:74
Value:$377
% of Portfolio:0.0% ($377/$6.4B)
Digimarc CORP
Shares:29
Value:$372
% of Portfolio:0.0% ($372/$6.4B)
SolarMax Technology, Inc.
Shares:302
Value:$362
% of Portfolio:0.0% ($362/$6.4B)
Kyverna Therapeutics, Inc.
Shares:186
Value:$359
% of Portfolio:0.0% ($359/$6.4B)
TScan Therapeutics, Inc.
Shares:259
Value:$357
% of Portfolio:0.0% ($357/$6.4B)
Applied Therapeutics, Inc.
Shares:726
Value:$355
% of Portfolio:0.0% ($355/$6.4B)
Alto Neuroscience, Inc.
Shares:161
Value:$348
% of Portfolio:0.0% ($348/$6.4B)
ACCURAY INC
Shares:194
Value:$347
% of Portfolio:0.0% ($347/$6.4B)
Niagen Bioscience, Inc.
Shares:50
Value:$345
% of Portfolio:0.0% ($345/$6.4B)
SEMrush Holdings, Inc.
Shares:37
Value:$345
% of Portfolio:0.0% ($345/$6.4B)
NERDWALLET, INC.
Shares:38
Value:$344
% of Portfolio:0.0% ($344/$6.4B)
GigaCloud Technology Inc
Shares:24
Value:$341
% of Portfolio:0.0% ($341/$6.4B)